InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vericel Corp

VCEL Clue Score63
United States Fiscal year ends December CIK 0000887359 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

35
Insider
Date
Role
Action
Shares
Price
Amount
Kevin F McLaughlin
12 Aug 2026
Director
Sold after exercise
7,000
$44.53
$311.71K
Michael Halpin
3 Aug 2026
Chief Operating Officer
Sold after exercise
10,000
$46.84
$468.40K
Jonathan Siegal
30 Jul 2026
Principal Accounting Officer
Sold after exercise
500
$48.90
$24.45K
Jonathan Siegal
30 Jul 2026
Principal Accounting Officer
Sold after exercise
2,500
$48.90
$122.25K
Jonathan Siegal
30 Jul 2026
Principal Accounting Officer
Sold after exercise
1,500
$48.90
$73.35K
Sean C. Flynn
26 Jun 2026
Chief Legal Officer
Sold after exercise
15,000
$45.64
$684.60K
Jonathan Mark Hopper
26 Jun 2026
Chief Medical Officer
Sold after exercise
5,000
$45.00
$225.00K
Jonathan Mark Hopper
26 Jun 2026
Chief Medical Officer
Sold after exercise
5,000
$45.00
$225.00K
Joseph Anthony Mara Jr
26 Jun 2026
Chief Financial Officer
Sold on a plan
5,000
$44.75
$223.75K
Jonathan Siegal
26 Jun 2026
Principal Accounting Officer
Sold after exercise
2,500
$44.90
$112.25K
Jonathan Siegal
26 Jun 2026
Principal Accounting Officer
Sold after exercise
232
$44.90
$10.42K
Sean C. Flynn
18 Jun 2026
Chief Legal Officer
Sold after exercise
15,000
$40.21
$603.15K
Michael Halpin
18 Jun 2026
Chief Operating Officer
Sold after exercise
10,000
$40.24
$402.40K
Jonathan Mark Hopper
2 Jun 2026
Chief Medical Officer
Sold after exercise
4,375
$35.00
$153.13K
Kevin F McLaughlin
13 May 2026
Director
Sold after exercise
3,500
$32.82
$114.87K
Kevin F McLaughlin
13 May 2026
Director
Sold after exercise
3,500
$32.83
$114.91K
Paul K Wotton
11 May 2026
Director
Sell
7,500
$32.64
$244.80K
Paul K Wotton
11 May 2026
Director
Sell
2,500
$33.05
$82.63K
Jonathan Siegal
7 May 2026
Principal Accounting Officer
Sold on a plan
1,422
$40.50
$57.59K
Joseph Anthony Mara Jr
7 May 2026
Chief Financial Officer
Sold on a plan
5,000
$40.50
$202.50K
Jonathan Siegal
6 May 2026
Principal Accounting Officer
Sold on a plan
3,433
$38.00
$130.45K
Jonathan Mark Hopper
2 Apr 2026
Chief Medical Officer
Sold after exercise
3,472
$35.00
$121.52K
Alan L Rubino
25 Mar 2026
Director
Exercised, kept
15,000
$2.76
$41.40K
Heidi Hagen
23 Mar 2026
Director
Sold after exercise
15,000
$32.41
$486.15K
Michael Halpin
2 Mar 2026
Chief Operating Officer
Sold on a plan
10,305
$35.30
$363.77K
Sean C. Flynn
2 Mar 2026
Chief Legal Officer
Sold after exercise
15,000
$35.36
$530.40K
Sean C. Flynn
2 Mar 2026
Chief Legal Officer
Sold after exercise
6,421
$34.75
$223.13K
Kevin F McLaughlin
11 Feb 2026
Director
Sold after exercise
7,000
$34.66
$242.62K
Michael Halpin
7 Jan 2026
Chief Operating Officer
Sold after exercise
10,000
$40.48
$404.80K
Paul K Wotton
3 Dec 2025
Director
Sell
2,500
$37.83
$94.58K
Paul K Wotton
2 Dec 2025
Director
Sell
2,500
$37.97
$94.93K
Jonathan Mark Hopper
2 Dec 2025
Chief Medical Officer
Sold after exercise
1,652
$39.14
$64.66K
Michael Halpin
11 Nov 2025
Chief Operating Officer
Sold after exercise
2,642
$40.41
$106.76K
Kevin F McLaughlin
10 Nov 2025
Director
Sold after exercise
7,000
$38.59
$270.13K
Michael Halpin
6 Nov 2025
Chief Operating Officer
Sold after exercise
7,358
$40.47
$297.78K

What was left out

Form 4 filings counted 45
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 25
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 361,147
History held since 16 Oct 2006